These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28826083)

  • 1. Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling.
    Rea D; Van Elzen R; De Winter H; Van Goethem S; Landuyt B; Luyten W; Schoofs L; Van Der Veken P; Augustyns K; De Meester I; Fülöp V; Lambeir AM
    Eur J Med Chem; 2017 Oct; 139():482-491. PubMed ID: 28826083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions.
    Watanabe YS; Yasuda Y; Kojima Y; Okada S; Motoyama T; Takahashi R; Oka M
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):981-8. PubMed ID: 26147347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of 4-(2,4,5-trifluorophenyl)butane-1,3-diamines as dipeptidyl peptidase IV inhibitors.
    Zhu L; Li Y; Qiu L; Su M; Wang X; Xia C; Qu Y; Li J; Li J; Xiong B; Shen J
    ChemMedChem; 2013 Jul; 8(7):1104-16. PubMed ID: 23671024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
    Ji X; Su M; Wang J; Deng G; Deng S; Li Z; Tang C; Li J; Li J; Zhao L; Jiang H; Liu H
    Eur J Med Chem; 2014 Mar; 75():111-22. PubMed ID: 24531224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaffold-hopping from xanthines to tricyclic guanines: A case study of dipeptidyl peptidase 4 (DPP4) inhibitors.
    Pissarnitski DA; Zhao Z; Cole D; Wu WL; Domalski M; Clader JW; Scapin G; Voigt J; Soriano A; Kelly T; Powles MA; Yao Z; Burnett DA
    Bioorg Med Chem; 2016 Nov; 24(21):5534-5545. PubMed ID: 27670099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4.
    Ohara-Nemoto Y; Nakasato M; Shimoyama Y; Baba TT; Kobayakawa T; Ono T; Yaegashi T; Kimura S; Nemoto TK
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28630069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1-c][1,2,4]-triazines and Pyrazolo[5,1-c][1,2,4]triazines as Potential Antidiabetic Agents.
    Rusinov VL; Sapozhnikova IM; Bliznik AM; Chupakhin ON; Charushin VN; Spasov AA; Vassiliev PM; Kuznetsova VA; Rashchenko AI; Babkov DA
    Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28393419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of 4-fluoropyrrolidine-2-carbonitrile and octahydrocyclopenta[b]pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
    Ji X; Xia C; Wang J; Su M; Zhang L; Dong T; Li Z; Wan X; Li J; Li J; Zhao L; Gao Z; Jiang H; Liu H
    Eur J Med Chem; 2014 Oct; 86():242-56. PubMed ID: 25164763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A time-resolved fluorescence probe for dipeptidyl peptidase 4 and its application in inhibitor screening.
    Kawaguchi M; Okabe T; Terai T; Hanaoka K; Kojima H; Minegishi I; Nagano T
    Chemistry; 2010 Dec; 16(45):13479-86. PubMed ID: 20938933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, structure-activity relationships, and docking studies of 1-(γ-1,2,3-triazol substituted prolyl)-(S)-3,3-difluoropyrrolidines as a novel series of potent and selective dipeptidyl peptidase-4 inhibitors.
    Zhang L; Su M; Li J; Ji X; Wang J; Li Z; Li J; Liu H
    Chem Biol Drug Des; 2013 Feb; 81(2):198-207. PubMed ID: 22994702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues.
    Roppongi S; Suzuki Y; Tateoka C; Fujimoto M; Morisawa S; Iizuka I; Nakamura A; Honma N; Shida Y; Ogasawara W; Tanaka N; Sakamoto Y; Nonaka T
    Sci Rep; 2018 Feb; 8(1):2714. PubMed ID: 29426867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors.
    Cox JM; Chu HD; Kuethe JT; Gao YD; Scapin G; Eiermann G; He H; Li X; Lyons KA; Metzger J; Petrov A; Wu JK; Xu S; Sinha-Roy R; Weber AE; Biftu T
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2622-6. PubMed ID: 27106708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of biofilm formation and dipeptidyl peptidase IV for the pathogenicity of clinical Porphyromonas gingivalis isolates.
    Clais S; Boulet G; Kerstens M; Horemans T; Teughels W; Quirynen M; Lanckacker E; De Meester I; Lambeir AM; Delputte P; Maes L; Cos P
    Pathog Dis; 2014 Apr; 70(3):408-13. PubMed ID: 24532232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of the active site of dipeptidyl peptidase IV from Porphyromonas gingivalis. Comparison with the human enzyme.
    Lambeir AM; Rea D; Fülöp V; Kumagai Y; Augustyns K; de Meester I; Haemers A; Scharpé S
    Adv Exp Med Biol; 2003; 524():29-35. PubMed ID: 12675220
    [No Abstract]   [Full Text] [Related]  

  • 15. Navigating the chemical space of dipeptidyl peptidase-4 inhibitors.
    Shoombuatong W; Prachayasittikul V; Anuwongcharoen N; Songtawee N; Monnor T; Prachayasittikul S; Prachayasittikul V; Nantasenamat C
    Drug Des Devel Ther; 2015; 9():4515-49. PubMed ID: 26309399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the Co-structures of dipeptidyl peptidase IV and its inhibitor.
    Nojima H; Kanou K; Terashi G; Takeda-Shitaka M; Inoue G; Atsuda K; Itoh C; Iguchi C; Matsubara H
    BMC Struct Biol; 2016 Aug; 16():11. PubMed ID: 27491540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique binding mode of Evogliptin with human dipeptidyl peptidase IV.
    Lee HK; Kim MK; Kim HD; Kim HJ; Kim JW; Lee JO; Kim CW; Kim EE
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):452-459. PubMed ID: 29061303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of dipeptidyl peptidase 4 inhibitory peptides from Largemouth bass (Micropterus salmoides) by a comprehensive approach.
    Wang K; Yang X; Lou W; Zhang X
    Bioorg Chem; 2020 Dec; 105():104432. PubMed ID: 33157343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SVMDLF: A novel R-based Web application for prediction of dipeptidyl peptidase 4 inhibitors.
    Chandra S; Pandey J; Tamrakar AK; Siddiqi MI
    Chem Biol Drug Des; 2017 Dec; 90(6):1173-1183. PubMed ID: 28585374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors.
    Mo DW; Dong S; Sun H; Chen JS; Pang JX; Xi BM; Chen WH
    Bioorg Med Chem Lett; 2015 May; 25(9):1872-5. PubMed ID: 25838146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.